CME Group Inc. (CME) stock traded at $272.36, up 1.40%, after the company released its third-quarter 2025 results.
CME Group Inc., CME
The derivatives marketplace operator reported mixed financial results, with earnings exceeding expectations despite a slight decline in revenue compared to the prior year.
For Q3 2025, CME Group reported revenue of $1.5 billion, a 2.9% decrease year-over-year. The company’s net income fell to $908 million, or $2.49 per share, compared to $901 million, or $2.50 per share, a year ago. On an adjusted basis, earnings reached $2.68 per share, beating the Zacks Consensus Estimate of $2.63.
The performance reflected lower clearing and transaction fees and reduced trading volumes across major asset classes. However, the bottom line matched last year’s strong results due to cost control and resilient market activity.
Clearing and transaction fees contributed $1.2 billion, while market data revenue hit a record $203 million. The average rate per contract stood at $0.702, maintaining solid fee generation.
Despite lower volumes in energy, foreign exchange, equity indexes, and interest rate products, CME achieved its second-highest third-quarter ADV ever at 25.3 million contracts. CEO Terry Duffy highlighted that global clients continued to rely on CME’s markets amid persistent uncertainty, helping sustain profitability.
Operating income for the quarter totaled $973 million, down 5% year-over-year, with total expenses increasing 0.8% to $565 million. As of September 30, 2025, CME held $2.6 billion in cash and $3.4 billion in debt.
The company paid $3.5 billion in dividends during the first nine months of 2025, bringing cumulative shareholder returns to over $29.5 billion since the start of its variable dividend policy in 2012.
Duffy emphasized CME’s ongoing focus on efficiency, innovation, and expanded access for market participants. Key initiatives include the new FanDuel partnership and 24/7 cryptocurrency futures and options trading, signaling CME’s commitment to growth and diversification.
As of October 22, 2025, CME stock has gained 18.95% year-to-date and 25.78% over the past year, outperforming the S&P 500’s 14.46% one-year return. Over five years, CME shares are up 104.20%, reflecting consistent value creation for investors despite short-term revenue pressures.
The post CME Group Inc. (CME) Stock: Rises as Q3 Earnings Beat Estimates Despite Revenue Dip appeared first on CoinCentral.